Niamh E. Buckley

1.9k total citations
55 papers, 1.4k citations indexed

About

Niamh E. Buckley is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Niamh E. Buckley has authored 55 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 23 papers in Oncology and 14 papers in Cancer Research. Recurrent topics in Niamh E. Buckley's work include Genomics and Chromatin Dynamics (6 papers), interferon and immune responses (5 papers) and BRCA gene mutations in cancer (5 papers). Niamh E. Buckley is often cited by papers focused on Genomics and Chromatin Dynamics (6 papers), interferon and immune responses (5 papers) and BRCA gene mutations in cancer (5 papers). Niamh E. Buckley collaborates with scholars based in United Kingdom, Ireland and United States. Niamh E. Buckley's co-authors include Paul B. Mullan, Richard D. Kennedy, D. Paul Harkin, Stephen McQuaid, Manuel Salto‐Tellez, Eileen E. Parkes, Nyree Crawford, Nuala McCabe, Karen D. McCloskey and Richard D. Wilkinson and has published in prestigious journals such as Nucleic Acids Research, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Niamh E. Buckley

54 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Niamh E. Buckley United Kingdom 22 765 582 319 273 153 55 1.4k
Christian Posch Austria 23 714 0.9× 575 1.0× 286 0.9× 123 0.5× 51 0.3× 81 1.5k
Francesco M. Marincola United States 15 426 0.6× 683 1.2× 716 2.2× 136 0.5× 84 0.5× 21 1.4k
Xiangcang Ye United States 19 975 1.3× 675 1.2× 113 0.4× 468 1.7× 55 0.4× 26 1.5k
Christof Winter Germany 20 896 1.2× 615 1.1× 270 0.8× 581 2.1× 201 1.3× 50 1.7k
A Peng China 9 896 1.2× 338 0.6× 93 0.3× 330 1.2× 64 0.4× 12 1.4k
Irina Kareva United States 16 307 0.4× 362 0.6× 178 0.6× 235 0.9× 85 0.6× 44 836
Andrew Redfern Australia 20 732 1.0× 703 1.2× 205 0.6× 439 1.6× 97 0.6× 102 1.6k
Karen Dybkær Denmark 23 716 0.9× 604 1.0× 545 1.7× 393 1.4× 75 0.5× 102 1.9k
Edward F. McClay United States 21 403 0.5× 757 1.3× 359 1.1× 87 0.3× 96 0.6× 57 1.3k
Lisa Simi Italy 27 801 1.0× 706 1.2× 113 0.4× 736 2.7× 60 0.4× 53 1.8k

Countries citing papers authored by Niamh E. Buckley

Since Specialization
Citations

This map shows the geographic impact of Niamh E. Buckley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niamh E. Buckley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niamh E. Buckley more than expected).

Fields of papers citing papers by Niamh E. Buckley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Niamh E. Buckley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niamh E. Buckley. The network helps show where Niamh E. Buckley may publish in the future.

Co-authorship network of co-authors of Niamh E. Buckley

This figure shows the co-authorship network connecting the top 25 collaborators of Niamh E. Buckley. A scholar is included among the top collaborators of Niamh E. Buckley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Niamh E. Buckley. Niamh E. Buckley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Glynn, Thomas J., et al.. (2025). Exploring the prognostic and predictive potential of bacterial biomarkers in non-gastrointestinal solid tumors. Expert Review of Molecular Diagnostics. 25(4). 117–128. 1 indexed citations
2.
McCarthy, Helen O., et al.. (2025). The search for a TNBC vaccine: the guardian vaccine. Cancer Biology & Therapy. 26(1). 2472432–2472432. 1 indexed citations
3.
Hanif, Ezanee Azlina Mohamad, Shudong Zhang, Niamh E. Buckley, et al.. (2024). A SRC-slug-TGFβ2 signaling axis drives poor outcomes in triple-negative breast cancers. Cell Communication and Signaling. 22(1). 454–454. 1 indexed citations
4.
Rolfe, Rebecca A., Nicholas Dunne, Niamh E. Buckley, et al.. (2024). Embryo movement is required for limb tendon maturation. Frontiers in Cell and Developmental Biology. 12. 1466872–1466872. 2 indexed citations
5.
McCarthy, Helen O., Niamh E. Buckley, Nicholas Dunne, et al.. (2024). Structural determinants of tendon multiscale mechanics and their sensitivity to mechanical stimulation during development in an embryonic chick model. Acta Biomaterialia. 190. 303–316. 4 indexed citations
6.
Tangney, Mark, et al.. (2023). Fusobacterium nucleatum: a novel immune modulator in breast cancer?. Expert Reviews in Molecular Medicine. 25. e15–e15. 22 indexed citations
7.
Dunne, Nicholas, et al.. (2022). Nucleic acid vaccination strategies for ovarian cancer. Frontiers in Bioengineering and Biotechnology. 10. 953887–953887. 4 indexed citations
8.
Parkes, Eileen E., Elaine S. Gilmore, Victoria Bingham, et al.. (2021). The clinical and molecular significance associated with STING signaling in breast cancer. npj Breast Cancer. 7(1). 81–81. 27 indexed citations
9.
Mukherjee, Debayan, Rebecca E. Steele, Adam Pickard, et al.. (2020). Investigating Radiotherapy Response in a Novel Syngeneic Model of Prostate Cancer. Cancers. 12(10). 2804–2804. 8 indexed citations
10.
Elkashif, Ahmed, Victoria Bingham, Matthew P. Humphries, et al.. (2020). Glucocorticoid Receptor Expression Predicts Good Outcome in response to Taxane-Free, Anthracycline-Based Therapy in Triple Negative Breast Cancer. Journal of Oncology. 2020. 1–10. 8 indexed citations
11.
Younos, Ibrahim, et al.. (2020). Trastuzumab cardiotoxicity in HER2-positive breast cancer patients in tertiary health care center, sultanate of Oman. Journal of Oncology Pharmacy Practice. 27(2). 312–321. 3 indexed citations
12.
Mulholland, Eoghan J., et al.. (2019). Exploring the Potential of MicroRNA Let-7c as a Therapeutic for Prostate Cancer. Molecular Therapy — Nucleic Acids. 18. 927–937. 21 indexed citations
13.
Cox, Órla T., Shelley J. Edmunds, Katja Simon‐Keller, et al.. (2019). PDLIM2 Is a Marker of Adhesion and β-Catenin Activity in Triple-Negative Breast Cancer. Cancer Research. 79(10). 2619–2633. 17 indexed citations
14.
Humphries, Matthew P., Seán O. Hynes, Victoria Bingham, et al.. (2018). Automated Tumour Recognition and Digital Pathology Scoring Unravels New Role for PD-L1 in Predicting Good Outcome in ER-/HER2+ Breast Cancer. Journal of Oncology. 2018. 1–14. 45 indexed citations
15.
Elkashif, Ahmed, et al.. (2018). Personalising the Fight against Triple Negative Breast Cancer. Research Portal (Queen's University Belfast). 1(1). 1 indexed citations
16.
Tornillo, Giusy, Howard Kendrick, Hasan Mirza, et al.. (2018). Dual Mechanisms of LYN Kinase Dysregulation Drive Aggressive Behavior in Breast Cancer Cells. Cell Reports. 25(13). 3674–3692.e10. 38 indexed citations
17.
Buckley, Niamh E., Claire Forde, Darragh G. McArt, et al.. (2016). Quantification of HER2 heterogeneity in breast cancer–implications for identification of sub-dominant clones for personalised treatment. Scientific Reports. 6(1). 23383–23383. 38 indexed citations
18.
Fleming, Padhraig S., Niamh E. Buckley, Jadbinder Seehra, Argy Polychronopoulou, & Nikolaos Pandis. (2012). Reporting quality of abstracts of randomized controlled trials published in leading orthodontic journals from 2006 to 2011. American Journal of Orthodontics and Dentofacial Orthopedics. 142(4). 451–458. 56 indexed citations
19.
Buckley, Niamh E., Karin Jirström, Elaine W. Kay, et al.. (2011). The ΔNp63 Proteins Are Key Allies of BRCA1 in the Prevention of Basal-Like Breast Cancer. Cancer Research. 71(5). 1933–1944. 34 indexed citations
20.
Mullan, Paul B., Alison M. Hosey, Niamh E. Buckley, et al.. (2005). The 2,5 oligoadenylate synthetase/RNaseL pathway is a novel effector of BRCA1- and interferon-γ-mediated apoptosis. Oncogene. 24(35). 5492–5501. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christian Posch Breakdown of academic impact, for papers by Francesco M. Marincola Breakdown of academic impact, for papers by Xiangcang Ye Breakdown of academic impact, for papers by Christof Winter Breakdown of academic impact, for papers by A Peng Breakdown of academic impact, for papers by Irina Kareva Breakdown of academic impact, for papers by Andrew Redfern Breakdown of academic impact, for papers by Karen Dybkær Breakdown of academic impact, for papers by Edward F. McClay Breakdown of academic impact, for papers by Lisa Simi
Rankless by CCL
2026